China Universal Asset Management Co., Ltd. Fibrogen Inc Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$0.79 - $2.83 $978 - $3,503	1,238 Added 96.79%	2,517 $2,000
Q3 2023 Oct 30, 2023	BUY	$0.79 - $2.83 $978 - $3,503	1,238 Added 96.79%	2,517 $2,000
Q2 2023 May 21, 2024	BUY	$2.49 - $20.59 $7 - $61	3 Added 0.24%	1,279 $3,000
Q2 2023 Jul 27, 2023	BUY	$2.49 - $20.59 $7 - $61	3 Added 0.24%	1,279 $3,000
Q1 2023 May 21, 2024	BUY	$15.95 - $25.18 $5,119 - $8,082	321 Added 33.61%	1,276 $23,000
Q1 2023 Apr 27, 2023	BUY	$15.95 - $25.18 $5,119 - $8,082	321 Added 33.61%	1,276 $24,000
Q4 2022 May 21, 2024	BUY	$13.27 - $17.73 $12,672 - $16,932	955 New	955 $15,000
Q4 2022 Jan 31, 2023	BUY	$13.27 - $17.73 $1,021 - $1,365	77 Added 8.77%	955 $15,000
Q3 2022 Oct 21, 2022	BUY	$11.4 - $14.6 $10,009 - $12,818	878 New	878 $11,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account